Life sciences distribution is shifting toward AI-powered, resilient networks that improve speed, efficiency, compliance, and patient care, according to experts at EY.
A complex Phase 1 neuropathy study with overnight stays achieved full enrollment and retention through careful planning, strong participant engagement, and disciplined operational execution.
In clinical trial disclosure, each country’s obligations are typically treated as separate, isolated tasks. This approach may appear efficient on the surface but can introduce major compliance risks.
Commercial launch readiness starts before approval. Early decisions on timing, manufacturing, validation, and partners determine whether clinical systems can scale.
Uncover how protocol screenability, site capacity, participant logistics, and recruitment handoffs affect enrollment momentum, along with early signals that can help teams spot where progress stalls.
